$600 Million
Joint Bookrunner
Follow-On
October 2022
$263 Million
Joint Bookrunner
Follow-On
October 2022
$350 Million
Exclusive Financial Advisor
Senior Secured Loan
October 2022
$150 Million
Exclusive Financial Advisor
Synthetic Royalty Financing Agreement
October 2022
$275 Million
Joint Bookrunner
Follow-On
October 2022
UNDISCLOSED
Exclusive Financial Advisor
Sale to Unified Women’s Healthcare
October 2022
UNDISCLOSED
Financial Advisor
Strategic Investment from Francisco Partners
October 2022
UNDISCLOSED
Capital Markets Advisor
Merger with European Biotech Acquisition Corp.
Pending
$76 Million
Placement Agent
PIPE
Pending
UNDISCLOSED
Exclusive Financial Advisor
Merger with Enliven Therapeutics
Pending
$125 Million
Joint Bookrunner
Follow-On
October 2022
$300 Million
Joint Bookrunner
Follow-On
October 2022